Clinical correlates of tobacco smoking in OCD: A UK, case-controlled, exploratory analysis by Sharma, Punita et al.
Clinical correlates of tobacco smoking in OCD:
A UK, case-controlled, exploratory analysis
PUNITA SHARMA1*, TIM M. GALE2,3 and NAOMI A. FINEBERG2,3,4
1Mott House Specialist Rehab Unit, West London Mental Health NHS Trust, Southall UB1 3EU, UK
2National OCDs Service, Hertfordshire Partnership NHS Foundation Trust, Queen Elizabeth II Hospital,
Welwyn Garden City, AL74HQ UK
3University of Hertfordshire, College Lane, Hatfield, Herts, UK
4Cambridge University School of Clinical Medicine, Addenbrookes Hospital, Cambridge, UK
(Received: May 29, 2012; revised manuscript received: August 12, 2012; accepted: August 18, 2012)
Background: Obsessive–compulsive disorder (OCD) is a biologically heterogeneous neuropsychiatric disorder. It is
associated with impulsive as well as compulsive neurocognitive mechanisms. Cigarette smoking is common among
most psychiatric patients; however, OCD patients are thought to show reduced rates. OCD smokers may thus repre-
sent a relatively uncommon OCD subtype, characterised by increased impulsivity. In this study, we aim to establish
the prevalence of smoking in a large, well-defined OCD cohort. We investigate whether smokers with OCD differ
from non-smokers with OCD on clinical measures of behavioural impulsivity and domains of personality and tem-
perament, including reward-dependence and novelty-seeking. Method: 183 of 200 outpatients with DSM-IV OCD
were interviewed to determine smoking status. A sub-sample of 10 smokers was compared with 10 non-smokers,
pair wise matched for age and gender. Patients were assessed for DSM co-morbidity, symptom profile, OCD sever-
ity, behavioural impulsivity and personality dimensions. Results: Only 10 individuals (5.46%; five males) were
smokers. Compared to OCD non-smokers, OCD smokers scored significantly higher on the Barratt Impulsiveness
Scale (p < 0.001). They also scored significantly higher on TCI measures of novelty seeking (p < 0.001) and reward
dependence (p < 0.001) and significantly lower on measures of harm avoidance (p < 0.001). Conclusions: Tobacco
smoking is rare in OCD. Significantly higher levels of behavioural impulsivity and temperamental factors associated
with reward driven impulsivity are seen in OCD smokers compared to non-smokers. Tobacco smoking may indicate
a possible source of neurocognitive heterogeneity in OCD.
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INTRODUCTION
Tobacco smoking is a leading behavioural health problem
and constitutes a prime cause of preventable premature
death. Approximately 21% of the UK population aged 16
years and over are smokers (General Household Survey,
2007). Tobacco smoking is more prevalent among psychiat-
ric patients than the general population (Amering et al.,
1999; Breslau, 1995; Breslau, Kilbey & Andreski, 1991;
Glassman, 1993; Hughes, Hatsukami, Mitchell & Dahlgren,
1986) and is particularly common among those with schizo-
phrenia, where the prevalence is extremely high (74%–88%)
compared with patients with other psychiatric diagnoses
(45% to 70%) (Bejerot & Humble, 1999). Five studies have
examined tobacco smoking in individuals with anxiety dis-
orders including OCD (Baker-Morissette, Gulliver, Wiegel
& Barlow, 2004; Bejerot & Humble, 1999; Himle, Thyer &
Fischer, 1988; McCabe et al., 2004). Of these, only one
study (Bejerot & Humble, 1999) specifically investigated
smoking habits among patients with OCD. According to the
published studies, the prevalence of smoking among pa-
tients with OCD appears to be low (7.7%–22.4%), compared
to other anxiety disorders and to psychiatric disorders in
general. It has been suggested that the lower occurrence of
smoking in OCD could be related to psychological, social or
medical factors. Thus, a low rate of smoking amongst OCD
patients may reflect constitutional factors that underpin
risk-avoidant behaviour in general. Alternatively, specific
symptoms intrinsic to the disorder, such as fear of bodily
harm and disease, parsimony or fear of causing a fire, may
deter individuals from smoking. Additionally, people with
OCD may be less socially integrated in early life, e.g. more
isolated at school, and therefore less susceptible to
peer-pressure to smoke, compared with their more socially
competent counterparts. An independent genetic factor
making smoking less rewarding, possibly related to the
cholinergic system, has also been proposed (Bejerot &
Humble, 1999).
AIMS
We investigated the possible link between tobacco smoking
and OCD by surveying attendees at a UK specialist OCD
outpatient clinic. Patients’ diagnoses were clearly estab-
lished and there was a range of illness severity and complex-
ity. Our primary hypotheses were that (1) the prevalence of
smoking in patients with DSM-IV OCD attending the clinic
ISSN 2062-5871 © 2012 Akadémiai Kiadó, Budapest
* Corresponding author: Dr P. Sharma, Mott House Specialist
Rehab Unit, West London Mental Health NHS Trust, Uxbridge
Road, Southall UB1 3EU, UK; E-mail: drpunitasharma@yahoo.
com
Journal of Behavioral Addictions 1(4), pp. 180–185 (2012)
DOI: 10.1556/JBA.1.2012.008
First published online September 25, 2012
would be low relative to population norms, and (2) OCD
smokers would be distinguishable from their non-smoking
counterparts in terms of clinical factors such as increased
levels of behavioural impulsivity; temperament and charac-
ter differences including decreased harm avoidance and in-
creased reward dependence; increased childhood psycho-
social maladjustment; increased OCD symptom-severity;
fewer OCD symptoms linked to harm; and increased
DSM-IV Axis I and II comorbidity.
METHOD
The study was approved by the Hertfordshire Research Eth-
ics Committee. Consecutive patients attending the Hertford-
shire Partnership NHS Foundation Trust Specialist OCD
Service were approached at the end of the clinic appoint-
ment. In addition, all past patients on the records for the last
five years were invited to attend an assessment at the Depart-
ment. All participants gave written informed consent and
were allowed time with an investigator to address any que-
ries. All study participants met the DSM-IV criteria for OCD
using the Mini International Neuropsychiatric Inventory –
MINI (Sheehan et al., 1998) supported by an extended clini-
cal interview with an expert clinician. In addition, for inclu-
sion, OCD needed to be the principal focus of clinical atten-
tion, or in the case of past patients, the priority for previous
treatment. Comorbidity was not excluded; instead comorbid
DSM disorders were assessed and noted from the extended
clinical interview.
Based upon a conservative estimate that 5–10% of OCD
patients would be smokers (Bejerot & Humble, 1999), 200
patients with OCD were approached. Out of these, 183
agreed to participate and attended a face-to-face interview.
All participants were assessed for current and previous
smoking habits, including numbers of cigarettes smoked
daily, on a questionnaire devised for the purpose (available
on request) as well as demographic variables such as age,
gender; age of onset of illness, current medication and sever-
ity of illness using standardised instruments.
The subsample of smokers (n = 10) and 10 non-smokers
(who had never smoked), derived from the same cohort and
selected using frequency matching, adjusting as closely as
possible for age and gender, were invited for a second visit.
The ‘case-control’ samples were rated for DSM-IV co-
morbidity using the Mini International Neuropsychiatric In-
ventory – MINI (Sheehan et al., 1998); symptom profiles us-
ing the Dimensional Yale–Brown Obsessive Compulsive
Scale – DYBOCS (Rosario-Campos et al., 2006); severity of
OCD using the Yale–Brown Obsessive Compulsive Scale –
YBOCS (Goodman et al., 1989); depression using the Mont-
gomery and Asberg Depression Rating Scale – MADRS
(Montgomery & Asberg, 1979); behavioural impulsivity us-
ing the Barrett Impulsiveness Scale – BIS (Patton, Stanford
& Barratt, 1995); temperament and character using the
Cloninger Temperament and Character Inventory – TCI
(Cloninger, 1994); global severity of illness using the Clini-
cal Global Impression-Severity Scale – CGI-S (Guy, 2000);
social adjustment using the Life Status Review (Stamm &
Rudolph,1996) and obsessive–compulsive personality pro-
file using the Compulsive Personality Assessment Scale –
CPAS (Ansseau,1996 ).
OCD smokers and non-smokers were compared on these
variables using statistical tests derived from IBM SPSS (Sta-
tistical Package for the Social Sciences). Continuous vari-
ables were compared with t-tests and proportions were com-
pared using Chi-Square (or Fisher’s exact test, when cell
counts were low). We additionally corrected for multiple
testing; as there were 10 different measures, the significance
level was set at p = 0.005.
RESULTS
Among 183 OCD patients assessed (78 males, 105 females),
all responded to questions about smoking habits. Both cur-
rent and previous smoking status was addressed. Current
smoking was defined as consumption of at least one ciga-
rette daily for the previous 3–6 months. Only 10 (5.46%;
5M:5F) were current smokers. For the purposes of our anal-
ysis, these were considered to be the ‘OCD smokers’. To-
bacco consumption varied from 0–22 smoking pack years,
ranging from two cigarettes per day for less than a year to 30
cigarettes per day for 20 years. Most of the OCD smokers
had concomitant mental disorders; four had major depres-
sive disorder while three had generalised anxiety disorder.
All the OCD smokers reported that smoking tobacco pro-
vided some relief from their OCD symptoms. One-hundred
and sixty-eight (91.8%) of the patients had never smoked
while five previous smokers had stopped without any major
difficulties. The most common reason given for never start-
ing smoking was simply lack of any interest in trying it. The
reasons for quitting smoking were predominantly “Had
enough of it” and “Was expensive”.
Table 1 compares the ten OCD smokers with the
subsample of ten OCD non-smokers on the clinical test vari-
ables. For each clinical test, a linear regression model was
run using the 3 predictor variables – smoking status, age and
gender. We determined the effect size (smokers vs.
non-smokers) for each test and, given the small sample size
in this study, we also determined the minimum sample size
required for non-significant effect sizes to become signifi-
cant (alpha = 0.05, beta = 0.1). These are reported in Table 1.
OCD smokers and OCD non-smokers differed on sev-
eral clinical measures. Smokers were significantly more im-
pulsive than non-smokers on the Barrett Impulsiveness
Scale (82.20, SD = 10.1) vs. (62.50, SD = 9.1) p < 0.001.
They also scored significantly higher on TCI measures of
novelty seeking (33.70, SD = 6.3) vs. (18.80, SD = 4.9), p <
0.001 and reward dependence (13.40, SD = 3.8) vs. (7.50,
SD = 2.4); p < 0.001 and significantly lower on measures of
harm avoidance (10.90, SD = 3.9) vs. (23.80, SD = 5.9)
p < 0.001. In addition, the smokers showed reduced
TCI-persistence (25.50, SD = 4.9) vs. (31.20, SD = 7.1) p <
0.02.
In contrast, there were no significant differences be-
tween the OCD smokers and non-smokers in the severity of
OCD; comorbidity rates; social adjustment measures; obses-
sive compulsive personality profile, and other character
variables including self-directedness, cooperativeness and
self-transcendence. Specifically, comorbid anxiety, depres-
sive disorder and a past history of depression were all com-
mon among the smokers, but without attaining statistical
significance, possibly owing to small numbers within the
test groups (see Table 1 for effect sizes and minimum sam-
ple sizes required for significance).
Regarding response to treatment; there were no signifi-
cant differences in the number of previous treatments, clini-
cal response to SSRI medication, use of antipsychotic aug-
mentation or duration of attendance at the OCD clinic.
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We formed an impression from surveying the case-notes
that the OCD smokers had poorer clinic attendance records,
resulting in them dropping out of the treatment after fewer
sessions when compared to the OCD non-smokers. How-
ever, as attendance was not specifically tested for, we were
not able to quantify this.
DISCUSSION
Our results suggest that OCD is associated with reduced to-
bacco smoking compared to population norms. The fre-
quency of OCD smokers identified in our study (5.46%) was
low even compared to rates previously reported in the litera-
ture (Table 2). This is relevant since we believe our study in-
vestigated the largest number (200) of OCD outpatients.
Cultural factors may influence rates of substance abuse
which can differ substantially across countries (Piko,
Luszczynska, Gibbons & Tekozel, 2004). Our findings ex-
tend the results of Bejerot and Humble (1999) in a Swedish
sample and suggest a strikingly low prevalence of to-
bacco-smoking among treatment-seeking UK OCD pa-
tients. They are also consistent with the results from a recent
large-scale US family-based case-control study that was un-
able to show a specific association between OCD and sub-
stance abuse (Wittchen et al., 2011). Our finding implies that
the presence of OCD may have a protective effect against
smoking. We may also infer that a small subgroup of OCD
patients, characterised by high levels of reward impulsivity,
is particularly susceptible to tobacco smoking and possibly
also to the pharmacological effects of nicotine.
Certain characteristics of temperament and behavioural
propensities have been linked to patients with substance
abuse disorders; the most salient variables being high nov-
elty-seeking (Cloninger, 1987; Zuckerman, 1983) and
impulsivity (Chiara, 2000) and low harm avoidance (Khan,
2005; Le Bon, 2004). In our study, OCD smokers were dis-
tinguishable from OCD non-smokers in terms of higher
scores on the BIS, TCI reward dependence and novelty
seeking scales and lower scores on the TCI harm avoidance
scales. These findings are consistent with behavioural and
temperamental correlates of greater ‘reward-driven’ impul-
sivity (Padhi, Mehdi, Craig & Fineberg, 2010). Reward-
driven impulsivity has previously been found to predict to-
bacco smoking and other substance and behavioural addic-
tions (Koob & Le Moal, 2001; Poulos, Le & Parker, 1995).
In contrast, OCD has been shown to be associated with in-
creased harm avoidance and lower self-directedness and
cooperativenesson the TCI (Cruz-Fuentes, Blas, Gonzalez,
Camarena & Nicolini, 2004). It would thus appear that rela-
tively elevated scores on the BIS, TCI Reward Dependence
scale and TCI Novelty Seeking scale and reduced scores on
the TCI Harm Avoidance scales are associated with the ex-
pression of smoking behaviour within the OCD population.
In the absence of a healthy control group, our study was un-
able to determine whether OCD smokers as a group show an
abnormally increased propensity toward reward-impulsivity
and/or OCD non-smokers show abnormally reduced re-
Table 1. Clinical variables in OCD smokers and OCD non-smokers: comparison of means (t-test for Equality of Means)
Variable Smoking status N Mean SD Sig (2-tailed) Effect size Min. sample size
(per group)
CPAS Smoker 10 23.50 3.80 .090 .36 44
Non-Smoker 10 21.20 1.87
CGI-S Smoker 10 4.00 1.05 .573 .12 122
Non-Smoker 10 3.80 .42
CGI-I Smoker 10 2.80 .78 .394 .19 79
Non-Smoker 10 3.10 .73
MADRS Smoker 10 36.80 9.61 .172 .32 49
Non-Smoker 10 30.80 8.23
BIS Smoker 10 82.20 10.17 .001 .71
Non-Smoker 10 62.50 9.15
Y-BOCS Smoker 10 12.50 2.63 .128 .21 72
Non-Smoker 10 11.40 2.45
TCI-NS Smoker 10 33.70 6.34 .001 .79
Non-Smoker 10 18.80 4.96
TCI-HA Smoker 10 10.90 3.95 .001 .79
Non-Smoker 10 23.80 5.99
TCI-RD Smoker 10 13.40 3.86 .001 .68
Non-Smoker 10 7.50 2.41
TCI-PE Smoker 10 25.50 4.90 .017 .42
Non-Smoker 10 31.20 7.17
TCI-SD Smoker 10 32.30 8.55 .153 .29 53
Non-Smoker 10 27.80 6.28
TCI-CO Smoker 10 14.30 5.18 .60 .12 122
Non-Smoker 10 13.10 4.72
TCI-ST Smoker 10 10.60 3.37 .79 .06 239
Non-Smoker 10 10.20 2.82
Note: CPAS – Compulsive Personality Assessment Scale; CGI – Clinical Global Impression; MADRS – Montgomery Asberg Depression Rating
Scale; BIS – Barratt Impulsiveness Scale; Y-BOCS – Yale–Brown Obsessive Compulsive Scale; TCI-NS – Temperament and Character Inven-
tory-Novelty Seeking; TCI-HA – Harm Avoidance; TCI-RD – Reward Dependence; TCI-PE – Persistence; TCI-SD – Self Directedness; TCI-CO –
Cooperativeness; TCI-ST – Self-Transcendence
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ward-impulsivity. Notwithstanding, smoking status appears
to act as a marker of clinical heterogeneity within the do-
main of impulsivity in OCD patients and a possible source of
confound in neurocognitive studies of compulsive/impul-
sive behavior within this patient-group.
Impulsivity is thought to be multidimensional and may
be fractionated into neuropsychologically distinct compo-
nents mediated by overlapping as well as distinct neural sub-
strates (Fineberg et al., 2010). Neurocognitive and brain-im-
aging studies have demonstrated that problems inhibiting
preplanned motor actions on laboratory tasks i.e. ‘motor
impulsivity’, mediated by activation within cortico-striatal
neurocircuitry, acts as vulnerability factor for OCD (Men-
zies et al., 2007). In contrast, substance addiction is associ-
ated with reward-driven impulsivity and abnormal ventral
reward circuitry (Fineberg et al., 2010). Serotonin and dopa-
mine interact across these circuits to modulate aspects of
both impulsive and compulsive responding and as yet un-
identified brain-based systems may also have important
functions (Fineberg et al., 2010).
OCD compulsions are traditionally viewed as behav-
iours designed to avert harmful consequences, and harm-
avoidance has been hypothesized to be a relevant psycho-
logical factor in the aetiology of OCD (Cruz-Fuentes et al.,
2004). Interestingly, in our study samples, the magnitude of
clinical impulsivity, and TCI reward dependence and harm
avoidance, did not appear to influence the phenome-
nological presentation of OCD. Specifically, despite signifi-
cant between-group differences in these measures, OCD
smokers were indistinguishable from non-smokers on key
clinical parameters including OCD symptom-profile
(Y-BOCS checklist), symptom-severity (Y-BOCS obses-
sion, compulsion and total score), psychiatric comorbidity,
social adjustment (Life Status Review) and obsessive com-
pulsive personality profile (CPAS). Our findings hint, there-
fore, that reward-driven impulsivity does not directly impact
upon the clinical expression of OCD and, perhaps contro-
versially, question the role of harm avoidance and reward
dependence mechanisms as relevant factors in the genera-
tion of OCD symptomatology. However, it is important to
acknowledge that the small numbers in our sample may have
obscured relevant differences.
In our sample of OCD smokers, nicotine was subjec-
tively experienced as anti-obsessional. Dopamine pathways
in the mesolimbic system have an important function in re-
ward and reinforcement (Wise, 2002). Nicotine depends on
dopamine-release for those behavioural effects that are most
relevant for its reinforcing properties (Chiara, 2000). It is
possible that smoking-induced dopamine release produces a
temporary anti-obsessional, or hedonic effect that patients
with OCD find therapeutic. Preliminary results suggesting a
positive effect for placebo-controlled single dose amphet-
amine challenge in OCD imply there may be a possible role
for compounds modulating dopamine release as a therapeu-
tic strategy (Pooley, Fineberg & Harrison, 2007). Our re-
sults suggest that further exploration of the clinical and
neurocognitive effect of tobacco-smoking and dopaminer-
gic modulation in OCD would be informative.
LIMITATIONS
Our sample-size was necessarily small, and the results must
be viewed as exploratory in nature, owing to the low fre-
quency of smoking in the OCD population. Other factors
aside from impulsivity and social adjustment, not tested in
this study, may additionally play a role in the expression of
smoking behaviour in OCD patients. For example, psycho-
social factors such as life satisfaction, academic achieve-
ment, future orientedness and degree of social comparison
have been found to correlate with smoking rates (Piko et al.,
2004) across different countries and cultures and may act as
mediating factors. Moreover this study was limited to UK
participants. Larger multinational cohorts are required to ad-
vance our understanding of the role of tobacco-smoking in
OCD.
CONCLUSIONS
We may conclude that tobacco smoking is rare in OCD.
OCD smokers appear to be distinguishable from their non-
smoking counterparts by significantly higher self-reported
behavioural impulsivity and temperamental factors associ-
ated with reward-driven impulsivity, coupled with lower
levels of harm-avoidance.
Table 2. Comparative frequency of smoking in OCD: a systematic
review of studies investigating OCD (including the current study)
Study Sample Principal Percentage
size diagnosis smokers
(%)
Bejerot & n = 83 Clinical OCD 14.5
Humble (1999) OCD association group 13.8
Psychiatric outpatient 42.0
group (non-OCD)
National normative sample 25.4
(1991)
Baker-Morissette n = 581 Panic disorder 19.2
et al. (2004) with/without agoraphobia
and agoraphobia without panic
GAD 17.2
Social phobia 13.6
Specific phobia 5.0
OCD 7.7
PTSD 0
Anxiety disorder not otherwise 4.6
specified
MDD 25.0
Total 14.9
McCabe et al. n = 155 Panic disorder 40.4
(2004) Social phobia 19.6
OCD 22.4
Himle et al. n = 163 Simple phobia 47
(2004) Social phobia 27
Agoraphobia 57
Panic disorder 47
GAD 29
OCD 9
Sharma et al. n = 183 OCD 5.46
(2012 – this paper)
Note: OCD – Obsessive–compulsive disorder; PTSD – Post-traumatic
stress disorder; GAD – Generalised anxiety disorder; MDD – Major de-
pressive disorder
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